PUBLISHER: TechNavio | PRODUCT CODE: 1626271
PUBLISHER: TechNavio | PRODUCT CODE: 1626271
Artificial Intelligence In Biotechnology Market 2025-2029
The artificial intelligence in biotechnology market is forecasted to grow by USD 4463.9 mn during 2024-2029, accelerating at a CAGR of 19% during the forecast period. The report on the artificial intelligence in biotechnology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by investments in biotechnology advancements, prevalence of chronic diseases, and increase in number of artificial intelligence-based biotech laboratories.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 18.2% |
CAGR | 19% |
Incremental Value | $4463.9 mn |
Technavio's artificial intelligence in biotechnology market is segmented as below:
By Application
By End-user
By Geographical Landscape
This study identifies the strategic collaborations as one of the prime reasons driving the artificial intelligence in biotechnology market growth during the next few years. Also, recent developments associated with artificial intelligence solutions in biotechnology industry and adoption of sustainable solutions will lead to sizable demand in the market.
The report on the artificial intelligence in biotechnology market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading artificial intelligence in biotechnology market vendors that include Abbott Laboratories, Amgen Inc., AstraZeneca Plc, BeiGene Ltd., Biogen Inc., Bristol Myers Squibb Co., CareDx Inc., Clario, F. Hoffmann La Roche Ltd., Genesis Therapeutics Inc., Insilico Medicine, Johnson and Johnson Inc., Merck KGaA, Novartis AG, Novo Nordisk AS, Pfizer Inc., Recursion Pharmaceuticals, Roivant Sciences Ltd., Sage Therapeutics Inc., and Sanofi SA. Also, the artificial intelligence in biotechnology market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: